Romanian Agency Reorganizes To Boost Performance & Face Brexit Challenge
Executive SummaryThe Romanian medicines agency is to be reorganized to improve the way it works and allow it to take on more work as a result of Brexit. One consequence is that industry fees may have to rise to pay for this work as well as a sharp rise in staff numbers.
You may also be interested in...
The bedding-in period is ending for Europe’s one-year-old system for preventing the circulation of fake medicines, and the scheme is gearing up for a more fully operational stage.
EU and US regulators have opposing views when it comes to Merck's applications for a new indication and new dosing schedule for the company's successful PD-1 inhibitor Keytruda.
Regulators have pulled out all the stops in their efforts to get the Ebola vaccine to the marketing authorization stage in Africa.